Cite
HARVARD Citation
Harshman, L. et al. (n.d.). 2619 Patterns and potential benefit of adjuvant chemotherapy for residual muscle invasive disease after neoadjuvant chemotherapy for muscle invasive urothelial cancer (MIUC). European journal of cancer. pp. S518-. [Online].